Loading...
Keywords
Last Name
Institution
Back to Search Results

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.

PropertyValue
information resource reference Ch?vez-Bueno S, Mej?as A, Merryman RA, Ahmad N, Jafri HS, Ramilo O. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients. Pediatr Infect Dis J. 2007 Dec; 26(12):1089-93.
label Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.

Search Criteria
  • Virus Diseases